All In Biotech

Drug Trial Radar · NCT00373685

GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)

Gastrointestinal (GI) Randomized Event And Safety Open-Label NSAID Study (GI-Reasons): A Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS) In Osteoarthritis Patients

Last checked: Nov 19, 2026Latest source record: Mar 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 8,067 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

8,067

Actual

Start

Oct 2006

Primary completion

Nov 2010

Study completion Nov 2010

Sponsor

Sponsor type
Industry
First posted
Sep 8, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 55 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study investigates if Celebrex has a lower incident of Gastrointestinal Events than other NSAIDS in subjects with osteoarthritis.

Conditions

  • Osteoarthritis

Interventions

  • CelecoxibDrug

    open-label

  • Any commercially available NSAID with the indication for osteoarthritisDrug

    dosing as per USPI label related to the chosen commercially marketed NSAID

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Clinically Significant Upper and/or Lower Gastrointestinal Events (CSULGIEs)Time frame: Baseline through week 24 or Early Termination (ET)

Locations

777 sites in 2 countries. Site status is shown where the registry gives one.

  • Pfizer Investigational Site

    Abbeville, Alabama

  • Pfizer Investigational Site

    Alexander City, Alabama

  • Pfizer Investigational Site

    Bay Minette, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Cullman, Alabama

  • Pfizer Investigational Site

    Dothan, Alabama

  • Pfizer Investigational Site

    Dothan, Alabama

  • Pfizer Investigational Site

    Geneva, Alabama

  • Pfizer Investigational Site

    Gulf Shores, Alabama

  • Pfizer Investigational Site

    Guntersville, Alabama

  • Pfizer Investigational Site

    Huntsville, Alabama

  • Pfizer Investigational Site

    Huntsville, Alabama

  • Pfizer Investigational Site

    Jacksonville, Alabama

  • Pfizer Investigational Site

    Mobile, Alabama

  • Pfizer Investigational Site

    Montgomery, Alabama

  • Pfizer Investigational Site

    Muscle Shoals, Alabama

  • Pfizer Investigational Site

    Ozark, Alabama

  • Pfizer Investigational Site

    Pell City, Alabama

  • Pfizer Investigational Site

    Tallassee, Alabama

  • Pfizer Investigational Site

    Chandler, Arizona

  • Pfizer Investigational Site

    Glendale, Arizona

  • Pfizer Investigational Site

    Green Valley, Arizona

  • Pfizer Investigational Site

    Mesa, Arizona

  • Pfizer Investigational Site

    Mesa, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Scottsdale, Arizona

  • Pfizer Investigational Site

    Sierra Vista, Arizona

  • Pfizer Investigational Site

    Sun Lakes, Arizona

  • Pfizer Investigational Site

    Tempe, Arizona

  • Pfizer Investigational Site

    Tempe, Arizona

  • Pfizer Investigational Site

    Tucson, Arizona

Showing 40 of 777 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.